{"id":"https://openalex.org/W4283364952","doi":"https://doi.org/10.3389/fonc.2022.744984","title":"PPP2CA Is a Novel Therapeutic Target in Neuroblastoma Cells That Can Be Activated by the SET Inhibitor OP449","display_name":"PPP2CA Is a Novel Therapeutic Target in Neuroblastoma Cells That Can Be Activated by the SET Inhibitor OP449","publication_year":2022,"publication_date":"2022-06-22","ids":{"openalex":"https://openalex.org/W4283364952","doi":"https://doi.org/10.3389/fonc.2022.744984","pmid":"https://pubmed.ncbi.nlm.nih.gov/35814385","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9258974"},"language":"en","primary_location":{"id":"doi:10.3389/fonc.2022.744984","doi":"https://doi.org/10.3389/fonc.2022.744984","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2022.744984","pdf_url":"https://www.frontiersin.org/articles/10.3389/fonc.2022.744984/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","datacite","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/articles/10.3389/fonc.2022.744984/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5049483642","display_name":"Celimene Galiger","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I196349391","display_name":"Universit\u00e4t Ulm","ror":"https://ror.org/032000t02","country_code":"DE","type":"education","lineage":["https://openalex.org/I196349391"]},{"id":"https://openalex.org/I4210155144","display_name":"University Hospital Ulm","ror":"https://ror.org/05emabm63","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210155144"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Celimene Galiger","raw_affiliation_strings":["Section of Experimental Pediatric Oncology, Department of Pediatrics and Adolescent Medicine, University Medical Center, Ulm, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Experimental Pediatric Oncology, Department of Pediatrics and Adolescent Medicine, University Medical Center, Ulm, Germany","institution_ids":["https://openalex.org/I196349391","https://openalex.org/I4210155144"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111856863","display_name":"Meike Dahlhaus","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I196349391","display_name":"Universit\u00e4t Ulm","ror":"https://ror.org/032000t02","country_code":"DE","type":"education","lineage":["https://openalex.org/I196349391"]},{"id":"https://openalex.org/I4210155144","display_name":"University Hospital Ulm","ror":"https://ror.org/05emabm63","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210155144"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Meike Dahlhaus","raw_affiliation_strings":["Section of Experimental Pediatric Oncology, Department of Pediatrics and Adolescent Medicine, University Medical Center, Ulm, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Experimental Pediatric Oncology, Department of Pediatrics and Adolescent Medicine, University Medical Center, Ulm, Germany","institution_ids":["https://openalex.org/I196349391","https://openalex.org/I4210155144"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000594249","display_name":"Michael Peter Vitek","orcid":"https://orcid.org/0000-0001-8140-8048","observed_orcids":["https://orcid.org/0000-0001-8140-8048"]},"institutions":[{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]},{"id":"https://openalex.org/I4210137828","display_name":"Cognosci (United States)","ror":"https://ror.org/03s5rph93","country_code":"US","type":"company","lineage":["https://openalex.org/I4210137828"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Peter Vitek","raw_affiliation_strings":["Cognosci, Inc., Research Triangle Park, NC, United States","Department of Neurology, Duke University Medical Center, Durham, NC, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cognosci, Inc., Research Triangle Park, NC, United States","institution_ids":["https://openalex.org/I4210137828"]},{"raw_affiliation_string":"Department of Neurology, Duke University Medical Center, Durham, NC, United States","institution_ids":["https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067061874","display_name":"Klaus\u2010Michael Debatin","orcid":"https://orcid.org/0000-0002-8397-1886","observed_orcids":["https://orcid.org/0000-0002-8397-1886"]},"institutions":[{"id":"https://openalex.org/I196349391","display_name":"Universit\u00e4t Ulm","ror":"https://ror.org/032000t02","country_code":"DE","type":"education","lineage":["https://openalex.org/I196349391"]},{"id":"https://openalex.org/I4210155144","display_name":"University Hospital Ulm","ror":"https://ror.org/05emabm63","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210155144"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Klaus-Michael Debatin","raw_affiliation_strings":["Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm, Ulm, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm, Ulm, Germany","institution_ids":["https://openalex.org/I196349391","https://openalex.org/I4210155144"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5009924186","display_name":"Christian P. Beltinger","orcid":"https://orcid.org/0000-0002-3527-9166","observed_orcids":["https://orcid.org/0000-0002-3527-9166"]},"institutions":[{"id":"https://openalex.org/I196349391","display_name":"Universit\u00e4t Ulm","ror":"https://ror.org/032000t02","country_code":"DE","type":"education","lineage":["https://openalex.org/I196349391"]},{"id":"https://openalex.org/I4210155144","display_name":"University Hospital Ulm","ror":"https://ror.org/05emabm63","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210155144"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"Christian Beltinger","raw_affiliation_strings":["Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm, Ulm, Germany","Section of Experimental Pediatric Oncology, Department of Pediatrics and Adolescent Medicine, University Medical Center, Ulm, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm, Ulm, Germany","institution_ids":["https://openalex.org/I196349391","https://openalex.org/I4210155144"]},{"raw_affiliation_string":"Section of Experimental Pediatric Oncology, Department of Pediatrics and Adolescent Medicine, University Medical Center, Ulm, Germany","institution_ids":["https://openalex.org/I196349391","https://openalex.org/I4210155144"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5009924186"],"corresponding_institution_ids":["https://openalex.org/I196349391","https://openalex.org/I4210155144"],"apc_list":{"value":2950,"currency":"USD","value_usd":2950},"apc_paid":{"value":2277,"currency":"EUR","value_usd":2455},"fwci":0.6731,"has_fulltext":true,"cited_by_count":11,"citation_normalized_percentile":{"value":0.65773712,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"12","issue":null,"first_page":"744984","last_page":"744984"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12226","display_name":"Neuroblastoma Research and Treatments","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12226","display_name":"Neuroblastoma Research and Treatments","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12104","display_name":"Protein Tyrosine Phosphatases","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11173","display_name":"Neurofibromatosis and Schwannoma Cases","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/neuroblastoma","display_name":"neuroblastoma","score":0.9789999723434448},{"id":"https://openalex.org/keywords/ppp2ca","display_name":"PPP2CA","score":0.9919999837875366},{"id":"https://openalex.org/keywords/protein-phosphatase-2a","display_name":"protein phosphatase 2A","score":0.949999988079071},{"id":"https://openalex.org/keywords/set-protein","display_name":"SET protein","score":0.7160000205039978},{"id":"https://openalex.org/keywords/dasatinib","display_name":"dasatinib","score":0.9459999799728394},{"id":"https://openalex.org/keywords/mycn","display_name":"MYCN","score":0.8069999814033508},{"id":"https://openalex.org/keywords/akt-phosphorylation","display_name":"Akt phosphorylation","score":0.9710000157356262},{"id":"https://openalex.org/keywords/tumor-suppressor-genes","display_name":"tumor suppressor","score":0.621999979019165},{"id":"https://openalex.org/keywords/drug-synergy","display_name":"drug synergy","score":0.5450000166893005},{"id":"https://openalex.org/keywords/therapeutic-target","display_name":"therapeutic target","score":0.527999997138977}],"concepts":[{"id":"https://openalex.org/C389152","wikidata":"https://www.wikidata.org/wiki/Q6593007","display_name":"Protein phosphatase 2","level":4,"score":0.8483343124389648},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6960757374763489},{"id":"https://openalex.org/C2779536868","wikidata":"https://www.wikidata.org/wiki/Q419940","display_name":"Dasatinib","level":4,"score":0.6799618005752563},{"id":"https://openalex.org/C75217442","wikidata":"https://www.wikidata.org/wiki/Q423650","display_name":"Protein kinase B","level":3,"score":0.6742733716964722},{"id":"https://openalex.org/C2776715637","wikidata":"https://www.wikidata.org/wiki/Q938205","display_name":"Neuroblastoma","level":3,"score":0.6707218289375305},{"id":"https://openalex.org/C178666793","wikidata":"https://www.wikidata.org/wiki/Q422476","display_name":"Phosphatase","level":3,"score":0.5491082072257996},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.5487892031669617},{"id":"https://openalex.org/C11960822","wikidata":"https://www.wikidata.org/wiki/Q242736","display_name":"Phosphorylation","level":2,"score":0.5189068913459778},{"id":"https://openalex.org/C2776912716","wikidata":"https://www.wikidata.org/wiki/Q4042503","display_name":"LY294002","level":4,"score":0.45039528608322144},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.407417893409729},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3854873776435852},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.33851221203804016},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.2611581087112427},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.15971991419792175},{"id":"https://openalex.org/C2777583451","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib","level":3,"score":0.14705422520637512},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.09021317958831787}],"mesh":[],"locations_count":6,"locations":[{"id":"doi:10.3389/fonc.2022.744984","doi":"https://doi.org/10.3389/fonc.2022.744984","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2022.744984","pdf_url":"https://www.frontiersin.org/articles/10.3389/fonc.2022.744984/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},{"id":"pmid:35814385","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35814385","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in oncology","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9258974","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9258974/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Oncol","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:33792a088fca4dea8283062f59d25b98","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/33792a088fca4dea8283062f59d25b98","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Oncology, Vol 12 (2022)","raw_type":"article"},{"id":"pmh:oai:oparu.uni-ulm.de:123456789/48188","doi":null,"is_oa":true,"landing_page_url":"http://nbn-resolving.de/urn:nbn:de:bsz:289-oparu-48188-2","pdf_url":null,"source":{"id":"https://openalex.org/S4306400353","display_name":"OPen Access Repositorium der Universit\u00e4t Ulm (OPARU) (Ulm University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I196349391","host_organization_name":"Universit\u00e4t Ulm","host_organization_lineage":["https://openalex.org/I196349391"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"doc-type:article"},{"id":"doi:10.18725/oparu-48112","doi":"https://doi.org/10.18725/oparu-48112","is_oa":true,"landing_page_url":"https://doi.org/10.18725/oparu-48112","pdf_url":null,"source":{"id":"https://openalex.org/S7407052964","display_name":"Universit\u00e4t Ulm, Kommunikations- und Informationszentrum (kiz)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Other"}],"best_oa_location":{"id":"doi:10.3389/fonc.2022.744984","doi":"https://doi.org/10.3389/fonc.2022.744984","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2022.744984","pdf_url":"https://www.frontiersin.org/articles/10.3389/fonc.2022.744984/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320321672","display_name":"Else Kr\u00f6ner-Fresenius-Stiftung","ror":"https://ror.org/03zcxha54"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4283364952.pdf","grobid_xml":"https://content.openalex.org/works/W4283364952.grobid-xml"},"referenced_works_count":55,"referenced_works":["https://openalex.org/W151043947","https://openalex.org/W1876581925","https://openalex.org/W1934704664","https://openalex.org/W1964241796","https://openalex.org/W1981083415","https://openalex.org/W1987468541","https://openalex.org/W1987474302","https://openalex.org/W1997664222","https://openalex.org/W2002996310","https://openalex.org/W2007312363","https://openalex.org/W2021359328","https://openalex.org/W2024280594","https://openalex.org/W2041393104","https://openalex.org/W2053645860","https://openalex.org/W2054177883","https://openalex.org/W2062500929","https://openalex.org/W2063337289","https://openalex.org/W2072802467","https://openalex.org/W2083832170","https://openalex.org/W2092838492","https://openalex.org/W2101603147","https://openalex.org/W2103562758","https://openalex.org/W2108146440","https://openalex.org/W2114625809","https://openalex.org/W2118071133","https://openalex.org/W2130925781","https://openalex.org/W2132546867","https://openalex.org/W2156509269","https://openalex.org/W2161954865","https://openalex.org/W2164324888","https://openalex.org/W2213548494","https://openalex.org/W2219761119","https://openalex.org/W2254902182","https://openalex.org/W2330923897","https://openalex.org/W2338302780","https://openalex.org/W2414539931","https://openalex.org/W2465000744","https://openalex.org/W2525339004","https://openalex.org/W2604499384","https://openalex.org/W2735132087","https://openalex.org/W2741508285","https://openalex.org/W2748185106","https://openalex.org/W2783732652","https://openalex.org/W2789089139","https://openalex.org/W2794385660","https://openalex.org/W2796129562","https://openalex.org/W2895571038","https://openalex.org/W2976174516","https://openalex.org/W2986129865","https://openalex.org/W3028754518","https://openalex.org/W3028798998","https://openalex.org/W3036199017","https://openalex.org/W3127273031","https://openalex.org/W3132931888","https://openalex.org/W4211147182"],"related_works":["https://openalex.org/W2895571038","https://openalex.org/W7124301624","https://openalex.org/W4404418037","https://openalex.org/W4399281519","https://openalex.org/W4224055432","https://openalex.org/W2901292274","https://openalex.org/W2057610072","https://openalex.org/W2760574993","https://openalex.org/W7162406275","https://openalex.org/W2017775327"],"abstract_inverted_index":{"Neuroblastoma":[0],"(NB)":[1],"is":[2,41],"the":[3,28,105,168],"most":[4],"common":[5],"extracranial":[6],"solid":[7],"tumor":[8,120,142],"in":[9,16,45,96,116,167,189],"childhood":[10],"and":[11,63,115,140,192,204,212],"has":[12],"a":[13,42,88,119,141,185,208],"poor":[14],"prognosis":[15],"high-risk":[17],"cases,":[18],"requiring":[19],"novel":[20,216],"therapies.":[21],"Pathways":[22],"that":[23,52,64],"depend":[24],"on":[25],"phospho-signaling":[26],"maintain":[27],"aggressiveness":[29],"of":[30,54,60,67,92,107,111,123,129,149,164,174,180,210],"NB.":[31,49,98,220],"Protein":[32],"phosphatase":[33,44],"2":[34],"(PP2A)":[35],"with":[36,118,207],"its":[37],"catalytic":[38],"subunit":[39],"PPP2CA":[40,55,68,130],"major":[43],"cancer":[46],"cells,":[47,109],"including":[48],"We":[50],"show":[51],"reduction":[53],"by":[56,69,84,159],"knock-down":[57],"decreased":[58,104,161],"growth":[59],"NB":[61,75,108],"cells":[62,76],"complete":[65],"ablation":[66],"knock-out":[70],"was":[71,94],"not":[72],"tolerated.":[73],"Thus,":[74],"are":[77,147,214],"addicted":[78],"to":[79,177,219],"PPP2CA,":[80],"an":[81,132],"addiction":[82],"augmented":[83],"MYCN":[85],"activation.":[86],"SET,":[87],"crucial":[89],"endogenous":[90],"inhibitor":[91,101,187],"PP2A,":[93],"overexpressed":[95],"poor-prognosis":[97],"The":[99,125],"SET":[100],"OP449":[102,160,193,211],"effectively":[103],"viability":[106,182],"independent":[110],"their":[112],"molecular":[113],"alterations":[114],"line":[117],"suppressor":[121,143],"function":[122],"PPP2CA.":[124],"contrasting":[126],"concentration-dependent":[127],"functions":[128],"as":[131],"essential":[133],"survival":[134],"gene":[135],"at":[136,144],"low":[137],"expression":[138],"levels":[139,146],"high":[145],"reminiscent":[148],"other":[150],"genes":[151],"showing":[152],"this":[153],"so-called":[154],"Goldilocks":[155],"phenomenon.":[156],"PP2A":[157],"reactivated":[158],"activating":[162,196],"phosphorylation":[163],"serine/threonine":[165],"residues":[166],"AKT":[169,175,197],"pathway.":[170],"Conversely,":[171],"induced":[172],"activation":[173],"led":[176],"partial":[178],"rescue":[179],"OP449-mediated":[181],"inhibition.":[183],"Dasatinib,":[184],"kinase":[186],"used":[188],"relapsed/refractory":[190],"NB,":[191],"synergized,":[194],"decreasing":[195],"phosphorylations.":[198],"In":[199],"summary,":[200],"concomitantly":[201],"reactivating":[202],"phosphatases":[203],"inhibiting":[205],"kinases":[206],"combination":[209],"dasatinib":[213],"promising":[215],"therapeutic":[217],"approaches":[218]},"counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":4}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2022-06-25T00:00:00"}